trending Market Intelligence /marketintelligence/en/news-insights/trending/zfvjoeximagvghkotqdrig2 content esgSubNav
In This List

Spring Bank Pharmaceuticals plans common stock offering

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Spring Bank Pharmaceuticals plans common stock offering

Spring Bank Pharmaceuticals Inc. is planning to undertake an underwritten public offering of its common stock.

The Hopkinton, Mass.-based biopharmaceutical company intends to grant the underwriters an option to buy up to an additional 15% of shares offered.

Spring Bank intends to use the net proceeds for funding clinical trials, nonclinical studies, research and development and for general corporate purposes.

Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the proposed offering.